01412nas a2200505   4500000000100000000000100001000000100002008004100003653002500044653001000069653003500079653005200114653003300166653001900199653003100218653001100249653003000260653002600290653003200316653005900348653002200407653001300429653002500442653003200467653001800499653001200517100001400529700001700543700001200560700001400572700001500586700001400601700001400615700001100629700001100640700001500651700001600666700001300682700001400695245014700709250001500856300001400871490000700885020001400892       2021                            d10aAdministration, Oral10aAdult10aAnticoagulants/adverse effects10a*Atrial Fibrillation/complications/drug therapy10a*Brain Ischemia/drug therapy10aCohort Studies10aDabigatran/adverse effects10aHumans10aPyridones/adverse effects10aRetrospective Studies10aRivaroxaban/adverse effects10a*Stroke/drug therapy/epidemiology/prevention & control10aTreatment Outcome10aWarfarin10a*atrial fibrillation10a*direct oral anticoagulants10a*epidemiology10a*stroke1 aM. Durand1 aM. Schnitzer1 aM. Pang1 aG. Carney1 aS. Eltonsy1 aK. Filion1 aA. Fisher1 aM. Jun1 aI. Kuo1 aA. Matteau1 aJ. Paterson1 aJ. Quail1 aC. Renoux00aEffectiveness and safety among direct oral anticoagulants in nonvalvular atrial fibrillation: A multi-database cohort study with meta-analysis  a2020/11/27  a2589-26010 v87  a0306-5251